Events

This year Cellecta and Nuvisan Innovation Campus, Berlin bring you an excellent case-study presentation on Phenotypic Screening Hit Target Deconvolution using Pooled CRISPR/Cas9 Screening Technology held at the 2021 Americal Association of Pharmaceutical Scientists (AAPS) National Biotechnology Conference.

This study will outline a target deconvolution strategy for novel potent small molecule inhibitors of YAP1/TAZ activity identified in a high-throughput screen of 3.8 million compounds. As a way to find the molecular target of the identified lead compound, pooled CRISPR/Cas9-KO screening targeting about 6000 human genes was conducted. PGGT1B, a subunit of the geranylgeranyltransferase I (GGTase I) complex, was validated as the direct target of the YAP1/TAZ pathway inhibitor.

From multiomics to immunoPCR and more, scientists are increasingly turning to bioconjugation to expand their molecular toolbox. Bioconjugation offers a way to chemically link two molecules to form a single hybrid, where at least one of the molecules in the partnership is a biomolecule. The resulting product retains the activity of each component, yet also gains a novel function that is not possible with either molecule alone. SoluLINK® bioconjugation technology is engineered for high-performance conjugation of all classes of biomolecules, including antibodies, proteins, peptides, oligonucleotides, carbohydrates, drugs, and surfaces. Join Vector Laboratories for this webinar where we will provide insights into bioconjugation to help you get started.

We’re back with another webinar! Join our panel of experts, including Bartek Makower and Marcus Buggert, as they dig into why T cells are the (not-so-secret) stars of COVID-19 research – plus how ELISpot and FluoroSpot techniques are already facilitating a remarkable global research effort.

Available throughout the year!

The British Society for Immunology has developed this series of webinars ‘Connecting on coronavirus: the expert hub’ to provide immunologists with a platform to keep informed with the latest developments on the Coronavirus outbreak by sharing relevant and timely information from expert sources. We’re in an unprecedented crisis in which constant global relief efforts result in around the clock activity. Now more than ever, we need to keep up to date and stay connected within the immunology community.

Available throughout the year!

With COVID-19 vaccine rollout now underway, there has never been a more important time for researchers to engage with the public around vaccination by listening and addressing common questions and concerns. BSI members and the wider research community are ideally placed to be expert sources of knowledge in these dialogues. Getting started in these conversations can seem daunting but this webinar will give you the tools you need to approach them in a constructive way and generate productive interactions.

Availabe throughout the year !

In this webinar, the head of Mabtech R&D, Dr Bartek Makower gives an overview of ELISpot and FluoroSpot in relation to Covid-19.

Available throughout the year!